Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Jb Chem Pharma
Join Channel

JB Chem & Pharma

₹2121.8 -9.8 | 0.5%

Last updated: 15:59

Consolidated Standalone

Last updated: 15:59

JB Chem & Pharma Overview

J. B. Chemicals & Pharmaceuticals Ltd is an pharmaceutical company. It is an incorporated, research-orientated organization, which is focused on imparting products both in India and International markets. The Company manufactures and markets a range of herbal remedies, pharmaceutical formulations, active pharmaceutical ingredient (APIs). The Company is engaged in manufacturing distinctiveness merchandise that comprises various pharmaceutical dosage forms like drugs, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, liq...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

JB Chem & Pharma Key Financials

Market Cap ₹34067 Cr.

Stock P/E 51.6

P/B 8.5

Current Price ₹2121.8

Book Value ₹ 249.4

Face Value 1

52W High ₹2140.3

Dividend Yield 0.73%

52W Low ₹ 1303

Edit Ratio

JB Chem & Pharma Share Price

₹ | |

Volume
Price

JB Chem & Pharma Quarterly Price

Quarterly Monthly
Show Value Show %

JB Chem & Pharma Peer Comparison

JB Chem & Pharma Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 882 845 862 1004 1001 963 949 1094 1085 1065
Other Income 8 7 17 6 10 8 14 15 15 18
Total Income 889 852 878 1010 1011 971 964 1108 1100 1083
Total Expenditure 638 621 664 724 730 709 723 793 775 769
Operating Profit 251 230 215 286 280 263 241 315 325 314
Interest 10 12 9 6 2 3 1 1 1 2
Depreciation 32 34 41 41 42 42 46 43 44 45
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 209 184 165 240 237 218 193 272 279 267
Provision for Tax 58 50 38 63 62 56 47 69 71 69
Profit After Tax 151 134 126 177 175 162 146 202 208 198
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 151 134 126 177 175 162 146 202 208 198
Adjusted Earnings Per Share 9.7 8.6 8.1 11.4 11.2 10.4 9.4 13 13.3 12.6

JB Chem & Pharma Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 1144 1232 1368 1414 1643 1775 2043 2424 3149 3484 3918 4193
Other Income 11 57 54 55 41 51 117 40 10 42 39 62
Total Income 1155 1288 1422 1469 1685 1826 2159 2464 3159 3526 3957 4255
Total Expenditure 964 1026 1140 1215 1337 1397 1486 1882 2454 2592 2887 3060
Operating Profit 191 263 283 254 347 428 673 583 706 934 1070 1195
Interest 7 11 5 3 5 3 7 5 36 44 12 5
Depreciation 39 41 47 57 56 66 69 73 114 138 171 178
Exceptional Income / Expenses 0 0 0 0 0 -10 0 0 0 0 0 0
Profit Before Tax 146 212 230 194 287 349 597 505 555 752 887 1011
Provision for Tax 45 50 46 55 93 77 148 119 145 199 228 256
Profit After Tax 100 163 184 139 194 272 449 386 410 553 660 754
Adjustments 0 -0 -0 -0 -1 -0 -1 -1 -0 0 0 0
Profit After Adjustments 100 163 184 138 193 272 448 385 410 553 660 754
Adjusted Earnings Per Share 5.9 9.6 10.9 8.3 12.1 17.6 29 24.9 26.5 35.6 42.4 48.3

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 12% 17% 17% 13%
Operating Profit CAGR 15% 22% 20% 19%
PAT CAGR 19% 20% 19% 21%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 40% 30% 29% 32%
ROE Average 22% 21% 22% 17%
ROCE Average 27% 25% 27% 22%

JB Chem & Pharma Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 995 1184 1364 1442 1480 1435 1810 2134 2480 2923 3433
Minority's Interest 0 2 2 3 3 3 4 4 0 0 0
Borrowings 0 0 0 0 0 0 0 0 383 24 0
Other Non-Current Liabilities 32 31 27 46 65 63 72 475 609 442 443
Total Current Liabilities 460 797 693 736 782 516 687 455 626 1288 1157
Total Liabilities 1487 2014 2086 2226 2329 2017 2572 3069 4098 4677 5033
Fixed Assets 329 440 679 640 621 651 634 1277 1901 2004 1968
Other Non-Current Assets 258 391 200 78 120 90 45 468 598 400 618
Total Current Assets 901 1182 1207 1509 1589 1276 1894 1325 1599 2273 2447
Total Assets 1487 2014 2086 2226 2329 2017 2572 3069 4098 4677 5033

JB Chem & Pharma Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 12 -5 7 -21 21 32 26 22 57 77 88
Cash Flow from Operating Activities 127 140 201 123 194 276 315 170 626 801 902
Cash Flow from Investing Activities -112 -28 -45 -21 -28 24 -231 2 -962 -404 -296
Cash Flow from Financing Activities -1 -100 -184 -60 -156 -306 -87 -138 357 -385 -580
Net Cash Inflow / Outflow 13 13 -28 43 11 -6 -3 34 20 11 27
Closing Cash & Cash Equivalent 25 9 -21 21 32 26 22 57 77 88 115

JB Chem & Pharma Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 5.92 9.58 10.85 8.28 12.06 17.6 28.98 24.93 26.48 35.61 42.37
CEPS(Rs) 8.2 12.02 13.65 11.71 15.55 21.91 33.46 29.68 33.89 44.52 53.36
DPS(Rs) 7 2.5 0.5 1 2.5 5.5 8.25 8.25 8.88 12.25 15.5
Book NAV/Share(Rs) 58.65 69.79 80.39 86.25 92.24 92.87 117.09 134.02 152.42 179.35 209.75
Core EBITDA Margin(%) 15.54 16.73 16.72 14.09 18.61 21.28 27.23 21.81 21.28 24.76 25.4
EBIT Margin(%) 13.15 18.1 17.2 13.97 17.75 19.84 29.58 20.5 18.09 22.08 22.15
Pre Tax Margin(%) 12.56 17.23 16.8 13.72 17.47 19.66 29.22 20.29 16.98 20.85 21.86
PAT Margin (%) 8.66 13.21 13.48 9.81 11.8 15.35 21.96 15.51 12.54 15.33 16.25
Cash Profit Margin (%) 12 16.55 16.93 13.84 15.19 19.09 25.32 18.44 16.04 19.17 20.46
ROA(%) 7.08 9.29 8.99 6.43 8.52 12.53 19.55 13.69 11.44 12.6 13.58
ROE(%) 9.86 14.93 14.48 9.89 13.28 18.69 27.64 19.89 18.51 21.49 21.81
ROCE(%) 13.49 17.83 16.87 13.7 19.59 23.71 36.53 25.48 22.79 25.23 26.73
Receivable days 78.41 79.28 71.84 73.15 67.63 67.22 65.62 69.29 63.16 63.93 67.54
Inventory Days 44.83 50.12 51.77 53.43 50.81 53.31 55.59 55.55 46.91 47.24 46.37
Payable days 73.91 62.53 62.76 70.44 69.69 82.55 92.33 89.07 72.35 91.86 106.33
PER(x) 16.9 13.01 15.99 18.68 14.91 14.44 21.63 31.59 37.21 46.32 38.29
Price/Book(x) 1.71 1.79 2.16 1.79 1.95 2.74 5.35 5.88 6.47 9.2 7.73
Dividend Yield(%) 7 2 0.29 0.65 1.39 2.16 1.32 1.05 0.9 0.74 0.96
EV/Net Sales(x) 1.57 1.86 2.18 1.83 1.75 2.21 4.74 5.01 4.99 7.42 6.42
EV/Core EBITDA(x) 9.42 8.74 10.54 10.15 8.28 9.17 14.4 20.84 22.28 27.68 23.49
Net Sales Growth(%) 11.97 7.64 11.1 3.32 16.23 8 15.09 18.69 29.91 10.63 12.45
EBIT Growth(%) 63.18 46.27 5.58 -16.09 47.71 20.75 71.55 -15.58 15.93 34.59 12.98
PAT Growth(%) 63.27 61.99 13.37 -24.77 39.83 40.43 64.66 -13.93 6.21 34.79 19.35
EPS Growth(%) 63.12 61.87 13.24 -23.72 45.66 45.99 64.66 -13.98 6.22 34.46 18.98
Debt/Equity(x) 0.13 0.16 0.04 0.02 0.02 0.02 0.02 0.01 0.23 0.13 0
Current Ratio(x) 1.96 1.48 1.74 2.05 2.03 2.47 2.76 2.91 2.56 1.77 2.12
Quick Ratio(x) 1.63 1.25 1.45 1.76 1.72 1.94 2.25 2.01 1.87 1.37 1.66
Interest Cover(x) 22.33 20.94 43.81 56.54 62.74 108.09 83.43 99.6 16.4 17.95 76.66
Total Debt/Mcap(x) 0.08 0.09 0.02 0.01 0.01 0.01 0 0 0.04 0.01 0

JB Chem & Pharma Shareholding Pattern

# Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 53.86 53.83 53.78 53.77 53.74 53.66 47.84 47.73 47.56 47.55
FII 10.05 10.35 11.05 12.17 13.61 14.62 18.28 17.77 15.3 14.88
DII 18.58 18.54 18.39 17.62 16.83 16.43 18.73 19.63 22.83 23.36
Public 17.51 17.28 16.78 16.43 15.82 15.29 15.14 14.88 14.3 14.22
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

JB Chem & Pharma News

JB Chem & Pharma Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 21%
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 47.55%.
  • Debtor days have increased from 91.86 to 106.33days.
  • Stock is trading at 8.5 times its book value.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!